We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ALCJ market cap is 72.72M. The company's latest EPS is EUR -0.2350 and P/E is -8.43.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.05M | 424k | 1.15M | 3.14M | 9.14M |
| Operating Income | -8.49M | -10.06M | -11.37M | -12.32M | -11.8M |
| Net Income | -7.17M | -9.84M | -10.81M | -11.16M | -8.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 24.49M | 33.59M | 31.53M | 32.86M | 28.64M |
| Total Liabilities | 21.48M | 34.72M | 37.01M | 30.17M | 33.91M |
| Total Equity | 3.01M | -1.13M | -5.48M | 2.69M | -5.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -5.51M | -5.46M | -6.08M | -5.08M | -6.2M |
| Investing | -4.4M | -6.1M | -6.73M | -6.78M | -2.64M |
| Financing | 13M | 11.93M | 14.52M | 9.64M | 3.36M |
| Market Cap | 72.72M |
| Price to Earnings Ratio | -8.43 |
| Price to Sales Ratio | 7.96 |
| Price to Cash Ratio | 31.58 |
| Price to Book Ratio | -13.82 |
| Dividend Yield | - |
| Shares Outstanding | 36.76M |
| Average Volume (1 week) | 46.15k |
| Average Volume (1 Month) | 87.23k |
| 52 Week Change | -53.79% |
| 52 Week High | 5.96 |
| 52 Week Low | 1.52 |
| Spread (Intraday) | 0.02 (1.01%) |
| Company Name | Crossject |
| Address |
6 rue pauline kergomard - zac parc mazen sully dijon, cote-d'or 21000 |
| Website | https://www.crossject.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
